BRASKEM S.A. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.785 USD | -1.18% |
|
+2.80% | -0.11% |
| Apr. 16 | Lummus and Braskem to Partner on Electrified Cracking Heater for Decarbonization | CI |
| Mar. 20 | Braskem Q4 Net Loss Shrinks, Revenue Drops -- Shares Surge | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- Low profitability weakens the company.
- The company is in debt and has limited leeway for investment
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.11% | 3.43B | - | ||
| +5.51% | 107B | A- | ||
| -5.51% | 63.84B | A- | ||
| +41.90% | 39.13B | B | ||
| +9.91% | 36.62B | B | ||
| +5.14% | 32.72B | A- | ||
| +6.11% | 19.19B | B- | ||
| +11.78% | 16.69B | C+ | ||
| +19.06% | 14.78B | B- | ||
| +5.70% | 14.73B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BRKM5 Stock
- BAK Stock
- Ratings Braskem S.A.
